Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
39,419,018
-
Shares change
-
+2,682,915
-
Total reported value, excl. options
-
$2,531,547,824
-
Value change
-
+$115,784,211
-
Put/Call ratio
-
126%
-
Number of buys
-
121
-
Number of sells
-
-89
-
Price
-
$64.22
Significant Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q4 2015
254 filings reported holding BLUE - BLUEBIRD BIO INC - COM as of Q4 2015.
BLUEBIRD BIO INC - COM (BLUE) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39,419,018 shares
.
Largest 10 shareholders include FMR LLC (5,501,537 shares), BAILLIE GIFFORD & CO (4,883,321 shares), Capital Research Global Investors (4,452,741 shares), VANGUARD GROUP INC (2,371,577 shares), Capital World Investors (2,075,000 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,005,303 shares), OppenheimerFunds, Inc. (1,316,324 shares), STATE STREET CORP (954,682 shares), ORBIMED ADVISORS LLC (941,700 shares), and BlackRock Institutional Trust Company, N.A. (879,313 shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.